KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to 0.2%.

  • Vertex Pharmaceuticals' Return on Capital Employed rose 2100.0% to 0.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.2%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.21% for FY2025, which is 2200.0% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.2% for Q4 2025, which was up 2100.0% from 0.2% recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Return on Capital Employed ranged from a high of 0.33% in Q2 2022 and a low of 0.04% during Q1 2025
  • For the 5-year period, Vertex Pharmaceuticals' Return on Capital Employed averaged around 0.19%, with its median value being 0.22% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -2600bps in 2024, then soared by 2200bps in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Return on Capital Employed stood at 0.26% in 2021, then grew by 15bps to 0.29% in 2022, then tumbled by -30bps to 0.21% in 2023, then plummeted by -106bps to 0.01% in 2024, then skyrocketed by 1677bps to 0.2% in 2025.
  • Its Return on Capital Employed stands at 0.2% for Q4 2025, versus 0.2% for Q3 2025 and 0.2% for Q2 2025.